BHK-21 cells persistently infected with foot-and-mouth disease virus (FMDV) can be cured of virus by treatment with the antiviral nucleoside analogue ribavirin. To study whether the process involved an increase in the number of mutations in the mutant spectrum of the viral population, viral genomes were cloned from persistently infected cells treated or untreated with ribavirin. An increase of up to 10-fold in mutation frequencies associated with ribavirin treatment was observed in the viral genomes from the treated cultures as compared with parallel, untreated cultures. To address the possible mechanisms of enhanced mutagenesis, we investigated the mutagenic effects of ribavirin together with guanosine, and mycophenolic acid in the presence or absence of guanosine. Changes in the intracellular nucleotide concentrations were determined for all treatments. The results suggest that the increased mutation frequencies were not dependent on nucleotide pool imbalances or due to selection of preexisting genomes but they were produced by a mutagenic action of ribavirin.
Introduction
Picornaviruses are the causative agents of many important human and animal diseases, associated with either acute or persistent infections (Racaniello, 2001; Semler and Wimmer, 2002) . Foot-and-mouth disease virus (FMDV) is a picornavirus of the genus Aphthovirus that causes the economically most important disease of farm animals worldwide (Sobrino et al., 2001) . FMDV usually causes an acute infection in animals, but it may also establish long-term persistent infections in ruminants (van Bekkum et al., 1959; Salt, 1993) and in cell culture (De la Torre et al., 1985) . During persistent infections of cattle established with biological clones of FMDV, continuous genetic and antigenic evolution of the virus, with rates of fixation of mutations of up to 7 ϫ 10 Ϫ2 substitutions per nucleotide and year, was recorded . A system of BHK-21 cells persistently infected with FMDV clone C-S8c1 was estab-lished (De la Torre et al., 1985) . The characterization of this system suggested a steady-state persistent infection, with the majority of cells displaying viral antigens, and the virus and cells undergoing a coevolutionary process in which the cells became gradually resistant to FMDV and the virus gradually more virulent for the parental BHK-21 cells Díez et al., 1990; Martin-Hernandez et al., 1994) . The nucleoside analogue ribavirin (1-␤-D-ribofuranosyl-1,2,3-triazole-3-carboxamide; Rib) was effective in eliminating FMDV from persistently infected cells (De la Torre et al., 1987) without significant decrease of cell viability, but the mechanism of its anti-FMDV activity is not known. Rib has shown antiviral activity against a number of RNA and DNA viruses (Sidwell et al., 1972; reviewed in Snell, 2001) . Rib is phosphorylated by cellular enzymes into ribavirin mono-, di-, and triphosphate (RMP, RDP and RTP, respectively) (Streeter et al., 1973; Zimmerman and Deeprose, 1978) and exerts its antiviral effect through various mechanisms: competitive inhibition of inosine monophosphate dehydrogenase (IM-PDH; EC 1.1.1.205), which reduces the intracellular concentrations of guanine nucleotides (Franklin and Cook, 1969; Streeter et al., 1973) , inhibition of some viral RNAdependent RNA polymerases (Eriksson et al., 1977; Wray et al., 1985a,b; Toltzis et al., 1988; Fernandez-Larsson et al., 1989) , inhibition of mRNA cap formation (Goswami et al., 1979; Scheidel and Stollar, 1991) , and enhancement of Th1 antiviral immune responses (Hultgren et al., 1998; Ning et al., 1998) . Recently, it has been shown that Rib exerts an antiviral action against poliovirus and hepatitis C virus (HCV) associated with enhanced mutagenesis, as a result of incorporation of RMP by poliovirus and HCV polymerases (Crotty et al., 2000 (Crotty et al., , 2001 Maag et al., 2001) . The mutagenic activity resulted from equal pairing of Rib with cytidine and uridine during viral RNA synthesis.
The present study was undertaken to investigate whether Rib-mediated curing of virus from cells persistently infected with FMDV involved enhanced mutagenesis of the virus. Since the effects of IMPDH inhibition can be reversed by addition of 100 M guanosine, compensating for the reduced de novo synthesis of guanine nucleotides (Zimmerman and Deeprose, 1978; Kerr, 1987; Landford et al., 2001) , we analyzed the effects of (1) Rib alone, (2) Rib together with guanosine, to measure the effects under conditions in which cellular GTP concentrations were not depleted, (3) mycophenolic acid (MPA), a noncompetitive inhibitor of IMPDH with apparently no other mechanisms of action, to measure the effects of IMPDH inhibition (Lowe et al., 1977; Lee et al., 1985; Sintchak et al., 1996) , and (4) MPA together with guanosine to study whether MPA had effects other than IMPDH inhibition. Nucleotide sequences of the regions coding for VP1 (capsid protein) and 3D (polymerase) of viral molecular clones were determined, and changes in intracellular nucleotide pools were analyzed. The results support a mutagenic action of Rib associated with curing of FMDV from persistently infected cells.
Results

Effects of antiviral treatments on viral production of persistent FMDV
Rib and MPA are inhibitors of the cellular enzyme IMPDH, and the effects of this inhibition can be reversed by addition of guanosine (Zimmerman and Deeprose, 1978; Kerr, 1987; Lanford et al., 2001) . In order to compare the antiviral efficiencies of these two IMPDH inhibitors, persistently infected cells of passage 40 were treated for 3 days with 100 or 500 M Rib, 15 M MPA, or standard culture medium, each of these in the presence or absence of up to 100 M guanosine ( Fig. 1) . None of the treatments had a clear antiviral effect during the first 24 h. High concentrations of guanosine in combination with 100 M Rib or 15 M MPA resulted in an increase of virus production during the first 24 h. After 2 days, the antiviral effect was evident in all treatments containing Rib or MPA. This antiviral effect was significantly suppressed by guanosine in a dosedependent manner (Fig. 1) . After 3 days, viral titers became barely detectable in treatments involving 100 or 500 M Rib together with 0 to 20 M guanosine, while 100 M guanosine was able to suppress the antiviral effect considerably. Treatments with MPA in combination with guanosine had similar results, but viral titers were somewhat higher in all cases. Hence, the antiviral effect of Rib was stronger than that of MPA against FMDV in persistently infected cells.
Effects of antiviral treatments on intracellular nucleotide pools
The drug concentrations used were adjusted in preliminary measurements so that the effects of the treatments with Fig. 1 . FMDV production by persistently infected cells subjected to various treatments. Samples were taken from the media at 1, 2, and 3 days after adding the drugs to the media on confluent cell monolayers. Culture medium was changed daily after samples were taken. A parallel control experiment without drugs cannot be described here, since in the absence of drugs, the high virus production in a confluent cell monolayer produced a cytopathic effect (de la Torre et al., 1985) . Results are the average of two experiments, and differences between corresponding samples did not exceed 1 logarithm. Procedures for cell culture and titration of FMDV are described under Materials and methods.
Rib and MPA in intracellular nucleotide pools should be similar. In order to verify this, samples were taken at various time points during each treatment, and nucleoside triphosphates were separated and quantitated by high-performance liquid chromatography (HPLC; typical chromatograms are shown in Figs. 2A and B ). The basal levels of intracellular ribonucleoside triphosphates in persistently infected BHK-21 cells were approximately half of those in uninfected BHK cells ( Fig. 2C ). Treatment of persistently infected cells with either Rib (100 or 500 M) or MPA (15 M) produced similar changes in the intracellular ribonucleoside triphosphate levels. As expected from the inhibi-tory effect of MPA and Rib on IMPDH (Fig. 3A) , GTP concentration was reduced 3-to 4-fold of its initial level during the first 4 to 8 h of treatment, and remained at similar levels after 3 days of culture. Addition of 100 M guanosine together with 500 M Rib produced a 5-fold increase in the GTP concentration ( Fig. 3B ); this guanosine concentration was used since 20 M guanosine was not sufficient to maintain GTP concentrations above the initial level for 24 h, and the higher concentration resulted in substantially elevated viral production in the presence of the drugs (Fig. 1 ). CTP and UTP levels were increased in 8 h up to 1.4-to 1.7-fold of their initial values, respectively, and then began declining toward the normal concentrations (data not shown). ATP levels were not affected by treatments with MPA or 100 M Rib, but exposure to 500 M Rib reduced ATP concentrations by 20 to 40%, possibly due to the use of ATP in the phosphorylation of Rib to RMP by adenosine kinase (Fig. 3A ). Since both Rib and MPA are inhibitors of IMPDH, treatments with these drugs should lead to accumulation of IMP. As expected, the IMP concentration rose more than 10-fold and about 30-fold from the initial level of approximately 0.001 fmol per cell due to treatments with 500 M Rib and 15 M MPA, respectively (data not shown).
Intracellular concentration of ribavirin triphosphate in cells persistently infected with FMDV
To determine the kinetics of intracellular accumulation of ribavirin triphosphate, persistently infected cells were extracted at different times after addition of Rib and the nucleotide concentrations were examined by HPLC. RTP was identified in the nucleotide pattern ( Fig. 2B ) by comparison with commercial RTP (Jena Bioscience). The intracellular RTP concentration reached a maximum of approximately 5 fmol/cell at 8 h after exposure and then decreased slightly during the next 16 h (Figs. 3C and D) . We conclude that Rib penetrates into BHK-21 cells persistently infected with FMDV, where it is converted into RTP that accumulates in the cells, and addition of Rib in culture media induces alterations of intracellular nucleotide pools expected from the inhibition of IMPDH.
Mutant spectrum complexity of persistent FMDV subjected to antiviral treatments with and without guanosine
To evaluate whether Rib might act as a mutagen of FMDV, and to study whether the possible mutagenic effects could be due to IMPDH inhibition and the resulting perturbations in the intracellular nucleotide concentrations, we determined the nucleotide sequences around the VP1-coding region and of the 3D-coding region of individual FMDV cDNA clones derived from persistent viral populations treated with 100 or 500 M Rib, or 15 M MPA, in the presence and absence of 100 M guanosine (Table 1 ). The FMDV genomic regions around the VP1-coding region (nucleotides 3193-3869) and the RNA-dependent RNA polymerase 3D (nucleotides 6610 -8019) were amplified and cloned under conditions designed to ensure that cDNA clones reflected the complexity of the RNA population (described under Materials and methods).
Mutation frequencies of FMDV produced by cells treated with Rib were 4 to 10 times higher than those found in virus from untreated cells, while Shannon entropies (a measurement of the number of different sequences in the mutant spectrum) increased 2-to 7-fold (Table 1 ). The addition of guanosine during Rib treatment did not affect significantly the complexity of the mutant spectrum of the 3D-coding region, and reduced less than 2-fold the com- In de novo synthesis of purine nucleotides, guanine derivatives are synthesized from IMP via xanthosine monophosphate (XMP), while adenine nucleotides are synthesized from IMP via adenylosuccinate. GTP is a phosphate donor for adenylosuccinate synthetase, and ATP is a phosphate donor for adenosine kinase. The presence of MPA or RMP results in GTP depletion through inhibition of IMPDH, and this effect can be compensated by addition of exogenous guanosine. Symbols: solid lines, metabolic reactions; double lines, inhibition; punctuated lines, donor molecules. The figure is based on previously published data (Franklin and Cook, 1969; Streeter et al., 1973; Lowe et al., 1977; Lee et al., 1985; Balzarini et al., 1991) . The intracellular RTP concentrations were roughly proportional to the Rib concentrations in the media, with 500 M Rib yielding apparently at least 5 times more RTP in the cells than 100 M Rib. However, RTP absorbed poorly at the 254 nm wavelength used, and therefore the concentrations achieved in the presence of 100 M Rib were close to the detection limit and could not be reliably quantitated. Assuming a cell volume of 3.6 ml/10 9 cells (Traut, 1994) , the maximal intracellular RTP concentration obtained was approximately 1.5 to 2 mM. The RTP peaks in the chromatograms were quantitated as described under Materials and methods.
plexity of the VP1-coding region. Therefore, Rib was found to be mutagenic to FMDV, and this effect was largely independent of the depletion of intracellular GTP concentration.
The MPA-induced mutation frequencies were 2.5-to 6-fold higher than in the untreated viral population, remaining clearly below the ones observed with Rib treatments (Table 1) . Shannon entropies increased 3-to 4-fold. Addition of guanosine in the MPA treatment abolished the mutagenic effect, suggesting that the mutations were due to IMPDH inhibition (Table 1) .
Types of mutations found
In treatments with 100 or 500 M Rib, with or without guanosine, a total of 57 mutations were found of the types C3 U and G3 A, and 11 mutations of the types U3 C and A3 G (Table 2) . Mutations C3 U and G3 A should be expected if mutations resulted from Rib incorporation opposite to C, while mutations U3 C and A3 G should be expected if mutations resulted from Rib incorporation opposite to U. In contrast to the results with Rib-treated populations, treatment with MPA did not show the same mutational bias: there were 10 mutations of the types C3 U and G3 A, and 9 mutations of the types U3 C and A3 G. Synonymous and nonsynonymous mutations were relatively uniformly distributed along the genomic regions analyzed (Fig. 4) . A total of 97 mutations were found in this study, 46 in the 3D-coding region (22 of which led to amino acid substitutions) and 51 in the VP1 region (25 amino acid substitutions). Since 3D consists of 470 amino acids and VP1 of 209 amino acids, the results show a lower acceptability of mutations in the polymerase-coding region. The results support a significant mutagenic effect of Rib associated with curing of FMDV from persistently infected cells.
Discussion
Persistently infected cells can be cured of FMDV by the nucleoside analogue Rib. Previous studies from several laboratories have indicated that Rib exerts its antiviral effects through different biochemical mechanisms, depending on the virus and the host cell (Malinoski and Stollar, 1981; Jordan et al., 1999) , and in many cases the antiviral effect cannot be ascribed to a single mechanism. Rib and MPA are both inhibitors of the cellular enzyme IMPDH, producing a significant reduction in the intracellular GTP concentration (Franklin and Cook, 1969; Streeter et al., 1973) . Contrary to Rib, there are no other known targets for MPA apart from IMPDH (Franklin and Cook, 1969; Lowe et al., 1977; Lee et al., 1985) . Treatment with MPA had a clear antiviral effect that was suppressed when GTP pools were restored by adding guanosine exogenously. Thus, MPA was able to reduce viral replication efficiency by altering the host cell ribonucleotide pools, as a result of IMPDH inhibition.
Treatment of cells with Rib reduced the intracellular GTP concentration 3-to 4-fold, in agreement with previous reports (Lowe et al., 1977; Wray et al., 1985b; Balzarini et The number of cDNA clones that were sequenced was 10 for each treatment for both VP1 and 3D, except for the VP1 region of clones obtained from the treatment with 15 M MPA, for which 20 clones were sequenced. This gives the total number of nucleotides sequenced, which is indicated in this column. c Mutation frequency is calculated dividing the number of different mutations found in the aligned sequences by the total number of nucleotides sequenced. d The normalized Shannon entropy is calculated as Ϫ[¥ i (p i ϫ ln p i )]/ln N, in which p i is the proportion of each sequence of the mutant spectrum and N is the total number of sequences compared (Volkenstein, 1994) . e Note that a larger number of VP1 clones was sequenced here.
al. , 1991) . Changes in ribonucleotide levels were similar to those observed with MPA, and therefore, the antiviral effects of these two compounds resulting from IMPDH inhibition should be similar. However, the antiviral effect of Rib was stronger, and while the effects of 15 M MPA and 100
M Rib were largely reversed by 100 M guanosine, treatment with 500 M Rib had a strong antiviral effect even in the presence of 100 M guanosine (Fig. 1) . In agreement with these observations, it has been previously shown that depending on the system, the antiviral effects of Rib may be Table 2 Types of mutations in the mutant spectrum of the persistent FMDV found after various antiviral treatments Number of mutants of each type after the indicated treatments a   R500  R500  R100  R100  MPA b  MPA  Control  G100  G100  G100   Transitions  A3G  --2  2  5  1  -U3C  3  3  1  -2  1  -G3A  5  8  6  3  3  1  -C3U  1 3  7  8  7  5  1  3  Transversions  A3C  1 
Mutation types
The treatments were as follows: R500, 500 M Rib; R100, 100 M Rib; MPA, 15 M mycophenolic acid; G100, 100 M guanosine; control, normal growth medium. The number of cDNA clones sequenced, the total number of mutations, and their consequences for mutant spectrum complexity associated with each treatment are summarized in Table 1 . Procedures for nucleotide sequence determination are described under Materials and methods. b Note that in this experiment, 20 clones of VP1 were sequenced instead of 10. Fig. 4 . Location of the mutations found in the VP1-and 3D-coding regions of FMDV after subjecting the persistently infected cells to various antiviral treatments. Each line represents the 10 clones sequenced from each population (20 clones from the VP1 region of the MPA-treated population). R500, 500 M Rib: R100, 100 M Rib; G0, no guanosine; G100, 100 M guanosine; MPA, 15 M MPA; Control, normal media without drugs. Symbols: amino acid substitutions (}); silent mutations (͉). Sequence numbering is according to (Escarmís et al., 1999) . Procedures for nucleotide sequence determination are described under Materials and methods.
either partially or mostly reversed by guanosine (Streeter et al., 1973; Wray et al., 1985b; Scheidel and Strollar, 1991; Jordan et al., 1999) , and that the dose-dependent antiviral activity can increase even when the additional drug has no further effect on GTP pools (Wray et al., 1985b) . In some systems the antiviral activity of Rib seems to be either independent of the IMPDH inhibition (Smee and Matthews, 1986) or limited to the same level as with other IMPDH inhibitors (Wray et al., 1986; Lanford et al., 2001) . Therefore, in some viral systems but not others, Rib possesses an antiviral activity that is independent of the effects on nucleotide pools.
Recent studies have raised the possibility that Rib could exert its action through increased mutagenesis (Crotty et al., 2000 (Crotty et al., , 2001 Maag et al., 2001; Contreras et al., 2002) . We found an increase in mutation frequencies due to treatments with either Rib or MPA, although the latter treatment resulted in a less pronounced increase in mutant spectrum complexity ( Table 1 ). The mutagenic effect of MPA was abolished by addition of guanosine, while that of Rib was only slightly reduced. The mutations found in MPA-treated populations were presumably due to an increased number of transition mutations that were favored by changes in the relative intracellular ribonucleotide concentrations, although there was no preference for C3 U and G3 A mutations that might be expected due to GTP depletion (Table  2) . Thus, Rib had an additional source of antiviral activity not ascribable to IMPDH inhibition that was consistent with mutagenesis through incorporation of Rib into the FMDV genomic RNA. As for other RNA viruses, FMDV replication is error prone and the mutation rates are close to an error threshold that sets a limit for maintenance of genetic information (Swetina and Schuster, 1982; Eigen and Biebricher, 1988; Holland et al., 1990; Drake and Holland, 1999; Eigen, 2000; Sierra et al., 2000; Pariente et al., 2001) . Curing of persistently infected cells from FMDV by Rib thus appears to provide yet another example of virus extinction through lethal mutagenesis (Eigen, 2002) .
Nucleotide sequencing of the VP1 and 3D genes of viral cDNA clones obtained from the mutant spectrum of persistent FMDV after various drug treatments indicates a mutagenic action of Rib. The observed Rib-induced mutation frequencies are close to those reported for poliovirus and HCV (Crotty et al., 2001; Contreras et al., 2002) . Mutation frequencies in untreated viral populations were similar to those found earlier in FMDV from persistent or cytolytic infections Sierra et al., 2000; Arias et al., 2001; Pariente et al., 2001) , while they were 2-to 10-fold higher in populations treated with Rib or MPA. The mutagenic effect of Rib was only mildly suppressed by guanosine addition, indicating that the mutations were not due to ribonucleotide pool imbalances resulting from IMPDH inhibition. The reduced amount of GTP might, however, favor incorporation of Rib into the viral RNA (RTP:GTP ratios were up to 10; compare Figs. 3B and D) , or increase the number of transition mutations through in-corporation of adenosine instead of guanosine. The latter possibility is less likely, since Rib decreased the ATP pools more than MPA, and therefore the GTP:ATP ratios were less affected by Rib treatment. It could be argued that Rib cured FMDV by some other mechanism and that the increase in mutant spectrum complexity was the result of dominance of minority components of the mutant spectrum. This is highly unlikely because minority genomes analyzed from FMDV mutant spectra rarely show a mutational bias of the type seen in the Rib-treated FMDV. Furthermore, in no previous case a mutant spectrum of FMDV showed an increase in complexity unless the population had been subjected to mutagenic treatments (Sierra et al., 2000; Pariente et al., 2001) . The amino acid substitutions were also rather uniformly distributed within both VP1 and 3D (Fig. 4) . In VP1, 43% of the mutations occurred at residues that were not accessible to the solvent Mateu et al., 1994) , implying a mutagenic action since during FMDV evolution, mutations mostly occur in the exposed residues of the capsid (Semler and Wimmer, 2002, and chapters therein) .
Rib treatment resulted in an increase in C3 U and G3 A mutations (Table 2) , as reported earlier for poliovirus (Crotty et al., 2000 (Crotty et al., , 2001 . The frequencies of the other two types of transition mutations (U3 C and A3 G) were much lower, and similar in all treatments. This is in contrast to what would be expected if Rib paired equally well with cytidine and uridine, as has been demonstrated for the poliovirus and HCV polymerases in vitro (Crotty et al., 2000 (Crotty et al., , 2001 Maag et al., 2001) . Mutations C3 U and G3 A should both occur if Rib is incorporated opposite to cytidine, either during negative strand synthesis (C3 U) or during positive strand synthesis (G3 A). It would be possible to explain the preference for these two mutations by favored Rib incorporation when the competing GTP is limited, or as a result of spontaneous transitions due to low GTP concentration. However, these explanations are not consistent with the data obtained with treatments involving Rib together with guanosine, since C3 U and G3 A mutations were more abundant in these viral populations as well. It seems that during FMDV replication Rib does have a preference to be incorporated opposite to cytidine instead of uridine, or that uridine is incorporated more frequently than cytidine when Rib is present in the template.
The mutation frequencies found in all Rib treatments, with or without guanosine, imply an average of 7 mutations per genome. Due to negative selection of at least the polymerase-coding region, it is possible that the actual mutagenic effect was stronger than that reflected by the clones sequenced, since the small difference in mutation frequencies obtained in treatments with 500 or 100 M Rib with 100 M guanosine (Table 1) is probably not sufficient to explain the large difference in the antiviral effects of these two treatments (Fig. 1) . Alternatively, other effects of Rib such as inhibition of viral RNA synthesis could participate in curing of FMDV (Snell, 2001) . Inhibition of cap forma-tion should not have an antiviral effect on FMDV, since picornaviruses use a cap-independent initiation of translation (Jang et al., 1988; Pelletier and Sonenberg, 1988) , and they do not depend on capped cellular mRNA molecules for replication (reviews in Semler and Wimmer, 2002) .
Rib-mediated mutagenesis has been reported for poliovirus, hepatitis C virus, Hantaan virus and possibly GB virus B (Crotty et al., 2000; Lanford et al., 2001; Maag et al., 2001; Contreras et al., 2002; Severson et al., 2003) , while no mutagenesis was found for lymphocytic choriomeningitis virus (LCMV) despite a potent antiviral effect of Rib (Ruíz-Jarabo et al., 2003) . The HCV RNA polymerase was found to incorporate Rib and to induce mutagenic base pairing, albeit less efficiently than the poliovirus RNA polymerase (Maag et al., 2001) , and Rib was mutagenic for HCV in a plasmid-based replication system (Contreras et al., 2002) . In HCV patients, however, no evidence of mutagenesis has been seen (Gerotto et al., 1999; Querenghi et al., 2001; Sookoian et al., 2001) , possibly due to the low Rib concentrations reached at the sites of viral replication. Consistent with earlier findings (Rankin et al., 1989) , we found Rib to accumulate inside the cells, yielding maximal concentrations of approximately 1.5 to 2 mM RTP in the presence of 500 M Rib in the medium (legend to Fig. 3D ). The maximal in vivo Rib concentration at the site of infection has been reported to be 600 to 800 M in respiratory fluids after small-particle aerosol administration , while intravenous administration was estimated to result in peak concentrations of approximately 20 -150 M in serum, which rapidly declined to levels as low as 1 M (Connor et al., 1993; Jordan et al., 2000) . Oral administration resulted in concentrations below 20 M in serum and 10 M in cerebrospinal fluid (Crumpacker et al., 1986; Ogle et al., 1989; Connor et al., 1993; Anderson and Rahal, 2002) . All these values in vivo are clearly lower than the concentrations that have been found to be mutagenic in cell culture, and they may not be sufficient for a significant mutagenic activity of RTP.
In summary, we have shown that the antiviral effect of Rib on FMDV in persistent infection is caused by at least two mechanisms: (1) direct mutagenesis and (2) imbalances in ribonucleotide pools resulting from IMPDH inhibition. Our results support Rib incorporation into viral RNA, but suggest that Rib does not pair equally well with cytidine and uridine. Further studies are needed to clarify the base pairing and incorporation properties of RTP by viral polymerases in vitro and to investigate whether intracellular concentrations of Rib could be high enough in vivo to allow significant incorporation of the drug in the viral RNA.
Materials and methods
Cells, viruses, and treatments
The baby hamster kidney cell line (BHK-21), persistently infected with FMDV C-S8c1, and procedures for its maintenance have been characterized previously (De la Torre et al., 1985 , 1987 . Persistently infected cells at passage 40 were used. Cells were shedding virus to the medium with maximal titers of about 10 5 PFU/ml Díez et al., 1990) . FMDV C-S8c1 is a plaque-purified derivative of the natural isolate C 1 Santa Pau-Spain/70 (Sobrino et al., 1983) . Drug treatments of persistently infected cells were initiated as the cell monolayers reached confluence. The cells were washed with normal medium [Dulbecco's modified Eagle's medium (Gibco) supplemented with nonessential amino acids (Gibco), 50 mg/ml gentamicin (Sigma), and 5% fetal calf serum (Gibco)], and new media were added, containing Rib (0, 100, or 500 M) or MPA (0 or 15 M; Sigma) in the presence or absence of guanosine (0, 5, 20, or 100 M; Sigma) . The media were changed daily, and samples from the media were taken immediately before each change. In the experiments with Rib or MPA, the drugs did not cause significant cytotoxicity, as initially confluent monolayers remained confluent during the 3 days of treatment. After 24 h, the number of viable cells had increased by 40 % in the untreated cultures, 15% in Rib-treated cultures, and 7% in MPA-treated cultures.
Sample preparation for high-performance liquid chromatography
To prepare samples from cell cultures for quantification of ribonucleotide levels by HPLC, we used the system described by Pogolotti and Santi (1982) , with minor modifications. Briefly, the cell monolayers (л 60 mm) were washed with phosphate-buffered saline, treated with 300 l of 0.6 M trichloroacetic acid, and incubated on ice for 10 min. The supernatants were collected and extracted with 1,1,2-trichlorotrifluoroethane (Sigma) containing 0.5 M trin-octylamine (Sigma). The mixtures were vortexed for 10 s and centrifuged 30 s at 12,000 g. The upper phase was collected and immediately frozen at Ϫ80°C, and upon thawing, the samples were analyzed immediately. The entire treatment was performed at 0 to 4°C, using ice-cold solutions. The ATP:ADP ratio was consistently above 20, indicating minimal loss of the terminal phosphate during sample preparation.
HPLC analysis of nucleotide pools
Nucleotides were separated using a 4.6 ϫ 250-mm Partisil 10 SAX column (Whatman) with a 4.6 ϫ 30-mm Partisil 10 SAX precolumn (Phenomenex). Around 25 pmol of nucleotides in a total volume of 100 l were analyzed. After washing the column with 18 ml of buffer A (7 mM NH 4 H 2 PO 4 , pH 3.8), nucleotides were eluted with a linear gradient prepared with 45 ml of buffer A and 45 ml of buffer B (250 mM NH 4 H 2 PO 4 , 500 mM KCl, pH 4.5), followed by a final wash with 30 ml of buffer B (Pogolotti and Santi, 1982) . The flow rate was 0.8 ml/min and the optical density of the eluant was continuously monitored at 254 nm. Nucleotide amounts were estimated from a standard curve obtained using samples containing known amounts of each nucleotide eluted under the same conditions. To correct for the fluctuations in the numbers of cells analyzed, peak sizes were normalized against the wellisolated and reproducible NAD peak of each sample, the concentration of which was not affected by any of the treatments. Chromatograms were analyzed using the Unicorn 3.00 software (Amersham Pharmacia Biotech). Nucleotide peaks were identified by comparison with the observed retention times of commercial solutions of RTP (Jena Bioscience), IMP, NAD (Sigma), ATP, ADP, CTP, GTP, and UTP (Amersham Pharmacia Biotech). In addition, the identity of the NAD peak was confirmed by mass spectroscopy as described below.
Mass spectrometry analysis
The identity of the presumed NAD peak was confirmed by analyzing by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry using an externally calibrated Reflex III instrument (Brucker-Franzen Analytic, Bremen, Germany) operating in the positiveion reflection mode. HPLC-collected fractions were lyophilized and resuspended in 50 l of distilled water. Part of this sample (5 l) was then mixed with 10 l of a 10 mg/ml solution of 2,4,6-trihydroxyacetophenone matrix in ethanol; 1 l of this mixture was dried down and subjected to analysis.
PCR, molecular cloning, and sequencing
Viral RNA was purified from 300 l of persistently infected cell culture supernatant using the RNeasy Mini Kit (Qiagen). Reverse transcription and PCR were performed with AMV reverse transcriptase (Promega) and high fidelity Pwo DNA polymerase (Roche). Primers for PCR amplification of the 3D polymerase-coding region were 5Ј-CAGAGCTCGACCCTGAACCGCA-3Ј (positions 6580 -6602 of the FMDV genome) and 5Ј-GCCCCGAATTCAT-TGTGC-3Ј (positions 8060 -8043), designed to create target sites for restriction endonucleases SacI and EcoRI, respectively. Primers for amplification of the VP1-coding region were 5Ј-CTTTGAGCTCCGGCTACCTGTG-3Ј (positions 3171-3192) and 5Ј-GAGAAGAAGAAGGGC-CCAGGGTTGGAC-3Ј (positions 3896 -3870), with target sites for restriction endonucleases SacI and BamHI, respectively. Numbering of residues in the FMDV genome is according to Escarmís et al. (1999) . The PCR products were digested using the indicated enzymes and ligated into the polycloning site of plasmid pGEM-4Z (Amersham). Competent Escherichia coli DH5␣ bacteria were transformed by the plasmid and plated, and individual colonies were picked for PCR amplification. PCR of the DNA from bacterial colonies, together with negative controls, were performed using AmpliTaq DNA polymerase (Perkin Elmer) and the primers described above. The PCR products were sequenced entirely in both orientations with an ABI sequencer using appropriately spaced primers, as previously described (Sierra et al., 2000; Pariente et al., 2001) .
Samples for the analysis of quasispecies complexity
Mutant spectrum heterogeneity was studied with viral populations that had been treated with drugs for 48 h, and some of these populations were approaching extinction at the time of RNA extraction. It was therefore essential to make sure that cloning and sequencing were performed reliably from individual clones that reflected the authentic RNA population rather than repeating the analysis with PCR products amplified from the same original viral RNA molecules. When analyzing n random amplification products from an RT-PCR performed with a sample containing D RNA molecules (D can be regarded as the last dilution found positive in PCR), the expected number of independent clones (E) is given by E ϭ D(1 Ϫ ((D Ϫ 1)/D) n [the formula is modified from Airaksinen and Hovi, 1998 ]. In the present work, 6 RT-PCR reactions were performed from each RNA sample. In addition to 3 independent reactions with undiluted RNA, reactions were also performed using samples diluted 1:10, 1:20, and 1:40. In cases where the 1:40 dilution was positive in RT-PCR, one of the RT-PCR obtained with undiluted RNA was used as the material for cloning. Under these conditions, sequencing 10 clones should give at least 8.9 independent sequences (D ϭ 40, n ϭ 10, E ϭ 8.9). When the 1:40 dilution was not positive but 1:20 or 1:10 were, all 3 RT-PCR from undiluted RNA were used in cloning, and the total of 10 sequences (4 ϩ 3 ϩ 3) were derived from the 3 parallel cloning procedures (E ϭ 9.4 or E ϭ 8.9 for dilutions 1:20 and 1:10, respectively). The results demonstrate that these precautions were sufficient, since only 3 different mutations, out of the 97 scored, were found twice in a single population. For determination of the mutation frequencies, generally 10 clones were sequenced of each of the seven persistent FMDV populations subjected to various antiviral treatments. The exact numbers of clones analyzed in each experiment are given under Results and Table 1. fellowship from MCyT (Spain). An institutional grant of Fundación Ramón Areces is also acknowledged.
